Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CXCR4”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 16 of 0 results

Not applicableEnded earlyNCT00321438
What this trial is testing

Observational Study of HIV-Infected Subjects With X4-Tropic or Non-Phenotypeable Virus

Who this might be right for
HIV Infection
GlaxoSmithKline 150
Not applicableLooking for participantsNCT06962163
What this trial is testing

Assessement of Potential Interest of [68Ga]Ga-PentixaFor PET/CT in Metastatic Triple Negative Breast Cancer Patients

Who this might be right for
Metastatic Breast Cancer
Institut Cancerologie de l'Ouest 12
Large-scale testing (Phase 3)Looking for participantsNCT06056297
What this trial is testing

Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections

Who this might be right for
Neutropenia
X4 Pharmaceuticals 176
Testing effectiveness (Phase 2)WithdrawnNCT02115672
What this trial is testing

Imatinib and BL-8040 (Novel Anti CXCR4 Antagonist) for Improving Molecular Response in Chronic Myelogenous Leukemia

Who this might be right for
Chronic Myeloid Leukemia
Sheba Medical Center
Testing effectiveness (Phase 2)Looking for participantsNCT06461182
What this trial is testing

Ga-68-CXCR4 PET/CT in Indolent B-cell Lymphoma

Who this might be right for
Indolent B-Cell Non-Hodgkin Lymphoma
Koo Foundation Sun Yat-Sen Cancer Center 15
Early research (Phase 1)Study completedNCT01272674
What this trial is testing

Adiponectin and Circulating Progenitor Cells (CPC) Function

Who this might be right for
Coronary Artery Disease
University of Leipzig 20
Early research (Phase 1)Study completedNCT04274738
What this trial is testing

Mavorixafor in Combination With Ibrutinib in Participants With Waldenstrom's Macroglobulinemia (WM) Whose Tumors Express Mutations in MYD88 and CXCR4

Who this might be right for
Waldenstrom's Macroglobulinemia
X4 Pharmaceuticals 16
Not applicableStudy completedNCT03891485
What this trial is testing

Nivolumab in mRCC Patients: Treg Function, T-cell Access and NK Interactions to Predict and Improve Efficacy

Who this might be right for
RCCMetastatic Renal Cell Carcinoma
National Cancer Institute, Naples 200
Testing effectiveness (Phase 2)Study completedNCT01072734
What this trial is testing

Auto-immunity in Lupus Patients After Influenza Vaccine

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Assistance Publique - Hôpitaux de Paris 28
Not applicableActive Not RecruitingNCT05818865
What this trial is testing

"Principle Test" for Isolation and Characterization of Circulating Cancer Cells (CTC)-CXCR4+.

Who this might be right for
Neoplasm Malignant
National Cancer Institute, Naples 47
Testing effectiveness (Phase 2)Study completedNCT00733824
What this trial is testing

Intravenous AMD3100 for Collection of Autologous Peripheral Blood Stem Cells in Patients With Lymphoma

Who this might be right for
Lymphoma, Non-HodgkinHodgkin Disease
Washington University School of Medicine 61
Early research (Phase 1)Study completedNCT01841476
What this trial is testing

Safety and Efficacy of POL6326 for Mobilization of Hematopoietic Stem Cells in Healthy Volunteers

Who this might be right for
Healthy
Polyphor Ltd. 27
Testing effectiveness (Phase 2)Study completedNCT04177810
What this trial is testing

Plerixafor and Cemiplimab in Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 25
Testing effectiveness (Phase 2)Ended earlyNCT02765165
What this trial is testing

Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)

Who this might be right for
Solid Tumors (Phase 1)Relapsed/Recurrent GBM (Phase 2)
Proximagen, LLC 26
Not applicableUnknownNCT06234319
What this trial is testing

CXCR4 PET/MRI Targeted Imaging for Grading Diagnosis, Molecular Typing, and Prognostic Evaluation of Brain Glioma

Who this might be right for
Glioma
Xiao Chen 60
Early research (Phase 1)Study completedNCT01120457
What this trial is testing

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

Who this might be right for
Acute Myelogenous LeukemiaDiffuse Large B-Cell LeukemiaChronic Lymphocytic Leukemia+1 more
Bristol-Myers Squibb 96